Trunk injection of the oxytetracycline hydrochloride formulation ReMedium TI for HLB treatment was given final clearance Jan. 11. The product began moving into the Florida citrus industry that same day. Consequently, the product’s manufacturer and the Citrus Research and Field Trial (CRAFT) Foundation both issued reminders and recommendations about the product’s use. Manufacturer TJ BioTech, LLC suggested the following things for growers …
New HLB Therapy Opens Door to Opportunities
By Peter Chaires The Florida citrus industry recently gained access to a newly approved HLB therapy for use on bearing citrus. In addition to new applications in the use of 2,4-D and gibberellic acid, growers now have a 24(c) special local needs label supporting direct application (injection) of oxytetracycline. It is no secret that industry recovery will require some combination …
Trunk Injection Soon to Become Reality in Florida Citrus
The Gulf Citrus Growers Association (GCGA) hosted a luncheon on Dec. 7 at the Southwest Florida Research and Education Center featuring a presentation by Tom Johnson, chief executive officer of TJ BioTech. The company is the manufacturer of ReMedium TI, the widely discussed formulation of oxytetracycline hydrochloride (OTC-HCI) that has shown promise as a treatment for HLB. The product is …